Cargando…
Factors associated with coronary heart disease in COPD patients and controls
BACKGROUND: COPD and coronary heart disease (CHD) frequently co-occur, yet which COPD phenotypes are most prone to CHD is poorly understood. The aim of this study was to see whether COPD patients did have a true higher risk for CHD than subjects without COPD, and to examine a range of potential fact...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045629/ https://www.ncbi.nlm.nih.gov/pubmed/35476713 http://dx.doi.org/10.1371/journal.pone.0265682 |
_version_ | 1784695356692365312 |
---|---|
author | Svendsen, Christina D. Kuiper, Karel K. J. Ostridge, Kristoffer Larsen, Terje H. Nielsen, Rune Hodneland, Vidar Nordeide, Eli Bakke, Per S. Eagan, Tomas M. |
author_facet | Svendsen, Christina D. Kuiper, Karel K. J. Ostridge, Kristoffer Larsen, Terje H. Nielsen, Rune Hodneland, Vidar Nordeide, Eli Bakke, Per S. Eagan, Tomas M. |
author_sort | Svendsen, Christina D. |
collection | PubMed |
description | BACKGROUND: COPD and coronary heart disease (CHD) frequently co-occur, yet which COPD phenotypes are most prone to CHD is poorly understood. The aim of this study was to see whether COPD patients did have a true higher risk for CHD than subjects without COPD, and to examine a range of potential factors associated with CHD in COPD patients and controls. METHODS: 347 COPD patients and 428 non-COPD controls, were invited for coronary computed tomography angiography (CCTA) and pulmonary CT. Arterial blood gas, bioelectrical impedance and lung function was measured, and a detailed medical history taken. The CCTA was evaluated for significant coronary stenosis and calcium score (CaSc), and emphysema defined as >10% of total area <-950 Hounsfield units. RESULTS: 12.6% of the COPD patients and 5.7% of the controls had coronary stenosis (p<0.01), whereas 55.9% of the COPD patients had a CaSc>100 compared to 31.6% of the controls (p<0.01). In a multivariable model adjusting for sex, age, body composition, pack-years, CRP, cholesterol/blood pressure lowering medication use and diabetes mellitus, the OR (95% CI) for having significant stenosis was 1.80 (0.86–3.78) in COPD patients compared with controls. In a similar model, the OR (95% CI) for having CaSc>100 was 1.68 (1.12–2.53) in COPD patients compared with controls. Examining the risk of significant stenosis and CaSc>100 among COPD patients, no variable was associated with significant stenosis, whereas male sex [OR 2.85 (1.56–5.21)], age [OR 3.74 (2.42–5.77)], statin use [OR 2.23 (1.23–4.50)] were associated with CaSc>100, after adjusting for body composition, pack-years, C-reactive protein, use of angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), diabetes, emphysema score, GOLD category, exacerbation frequency, eosinophilia, and hypoxemia. CONCLUSION: COPD patients were more likely to have CHD, but neither emphysema score, lung function, exacerbation frequency, nor hypoxemia predicted presence of either coronary stenosis or CaSc>100. |
format | Online Article Text |
id | pubmed-9045629 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-90456292022-04-28 Factors associated with coronary heart disease in COPD patients and controls Svendsen, Christina D. Kuiper, Karel K. J. Ostridge, Kristoffer Larsen, Terje H. Nielsen, Rune Hodneland, Vidar Nordeide, Eli Bakke, Per S. Eagan, Tomas M. PLoS One Research Article BACKGROUND: COPD and coronary heart disease (CHD) frequently co-occur, yet which COPD phenotypes are most prone to CHD is poorly understood. The aim of this study was to see whether COPD patients did have a true higher risk for CHD than subjects without COPD, and to examine a range of potential factors associated with CHD in COPD patients and controls. METHODS: 347 COPD patients and 428 non-COPD controls, were invited for coronary computed tomography angiography (CCTA) and pulmonary CT. Arterial blood gas, bioelectrical impedance and lung function was measured, and a detailed medical history taken. The CCTA was evaluated for significant coronary stenosis and calcium score (CaSc), and emphysema defined as >10% of total area <-950 Hounsfield units. RESULTS: 12.6% of the COPD patients and 5.7% of the controls had coronary stenosis (p<0.01), whereas 55.9% of the COPD patients had a CaSc>100 compared to 31.6% of the controls (p<0.01). In a multivariable model adjusting for sex, age, body composition, pack-years, CRP, cholesterol/blood pressure lowering medication use and diabetes mellitus, the OR (95% CI) for having significant stenosis was 1.80 (0.86–3.78) in COPD patients compared with controls. In a similar model, the OR (95% CI) for having CaSc>100 was 1.68 (1.12–2.53) in COPD patients compared with controls. Examining the risk of significant stenosis and CaSc>100 among COPD patients, no variable was associated with significant stenosis, whereas male sex [OR 2.85 (1.56–5.21)], age [OR 3.74 (2.42–5.77)], statin use [OR 2.23 (1.23–4.50)] were associated with CaSc>100, after adjusting for body composition, pack-years, C-reactive protein, use of angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), diabetes, emphysema score, GOLD category, exacerbation frequency, eosinophilia, and hypoxemia. CONCLUSION: COPD patients were more likely to have CHD, but neither emphysema score, lung function, exacerbation frequency, nor hypoxemia predicted presence of either coronary stenosis or CaSc>100. Public Library of Science 2022-04-27 /pmc/articles/PMC9045629/ /pubmed/35476713 http://dx.doi.org/10.1371/journal.pone.0265682 Text en © 2022 Svendsen et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Svendsen, Christina D. Kuiper, Karel K. J. Ostridge, Kristoffer Larsen, Terje H. Nielsen, Rune Hodneland, Vidar Nordeide, Eli Bakke, Per S. Eagan, Tomas M. Factors associated with coronary heart disease in COPD patients and controls |
title | Factors associated with coronary heart disease in COPD patients and controls |
title_full | Factors associated with coronary heart disease in COPD patients and controls |
title_fullStr | Factors associated with coronary heart disease in COPD patients and controls |
title_full_unstemmed | Factors associated with coronary heart disease in COPD patients and controls |
title_short | Factors associated with coronary heart disease in COPD patients and controls |
title_sort | factors associated with coronary heart disease in copd patients and controls |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045629/ https://www.ncbi.nlm.nih.gov/pubmed/35476713 http://dx.doi.org/10.1371/journal.pone.0265682 |
work_keys_str_mv | AT svendsenchristinad factorsassociatedwithcoronaryheartdiseaseincopdpatientsandcontrols AT kuiperkarelkj factorsassociatedwithcoronaryheartdiseaseincopdpatientsandcontrols AT ostridgekristoffer factorsassociatedwithcoronaryheartdiseaseincopdpatientsandcontrols AT larsenterjeh factorsassociatedwithcoronaryheartdiseaseincopdpatientsandcontrols AT nielsenrune factorsassociatedwithcoronaryheartdiseaseincopdpatientsandcontrols AT hodnelandvidar factorsassociatedwithcoronaryheartdiseaseincopdpatientsandcontrols AT nordeideeli factorsassociatedwithcoronaryheartdiseaseincopdpatientsandcontrols AT bakkepers factorsassociatedwithcoronaryheartdiseaseincopdpatientsandcontrols AT eagantomasm factorsassociatedwithcoronaryheartdiseaseincopdpatientsandcontrols |